Milestone Pharmaceuticals Inc. (MIST) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
MIST Revenue Analysis (2017–2024)
As of March 2, 2026, Milestone Pharmaceuticals Inc. (MIST) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, MIST's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $15.0 million in 2021.
When compared to Healthcare sector peers including UTHR (+10.6% YoY), ZLAB (+15.3% YoY), and AMRN (-6.2% YoY). Compare MIST vs UTHR →
Peer Comparison
Compare MIST's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MISTCurrent | $0 | - | - | - | |
| UTHR | $3.2B | +10.6% | +16.5% | 46.9% | |
| ZLAB | $460M | +15.3% | +56.5% | -49.9% | |
| AMRN | $229M | -6.2% | -11.9% | -40.2% | |
| ALKS | $1.5B | -5.2% | +7.3% | 17.2% | |
| ADMA | $426M | +27.6% | +70.8% | 32.6% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | -100.0% | $0 | - | $-42,102,000 | - |
| 2023 | $1.0M | -80.0% | $1.0M | 100.0% | $-61,098,000 | -6109.8% |
| 2022 | $5.0M | -66.7% | $5.0M | 100.0% | $-59,642,000 | -1192.8% |
| 2021 | $15.0M | - | $15.0M | 100.0% | $-43,073,000 | -287.2% |
| 2020 | $0 | - | $0 | - | $-50,710,000 | - |
| 2019 | $0 | - | $0 | - | $-57,881,000 | - |
| 2018 | $0 | - | $-10,000 | - | $-23,822,000 | - |
| 2017 | $0 | - | $-8,000 | - | $-8,268,000 | - |
See MIST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MIST Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare MIST vs AGIO
See how MIST stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is MIST's revenue growth accelerating or slowing?
MIST TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is MIST's long-term revenue growth rate?
Milestone Pharmaceuticals Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is MIST's revenue distributed by segment?
MIST reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.